226
Participants
Start Date
May 31, 2006
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
lamotrigine, 300 mg/day
300 mg/day
lamotrigine, 250 mg/day
250 mg/day
GSK Investigational Site, Capital Federal
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Lawrence
GSK Investigational Site, Plainview
GSK Investigational Site, Syracuse
GSK Investigational Site, Sellersville
GSK Investigational Site, Philadelphia
GSK Investigational Site, Newark
GSK Investigational Site, Bethesda
GSK Investigational Site, Vinnitsa
GSK Investigational Site, Glen Burnie
GSK Investigational Site, Pikesville
GSK Investigational Site, Charleston
GSK Investigational Site, Morgantown
GSK Investigational Site, Asheville
GSK Investigational Site, Decatur
GSK Investigational Site, Atlanta
GSK Investigational Site, Atlanta
GSK Investigational Site, Jacksonville
GSK Investigational Site, Sunrise
GSK Investigational Site, Loxahatchee Groves
GSK Investigational Site, Tampa
GSK Investigational Site, Alabaster
GSK Investigational Site, Hattiesburg
GSK Investigational Site, Louisville
GSK Investigational Site, Lexington
GSK Investigational Site, Lexington
GSK Investigational Site, Detroit
GSK Investigational Site, Dnipro
GSK Investigational Site, Des Moines
GSK Investigational Site, Milwaukee
GSK Investigational Site, Madison
GSK Investigational Site, Minneapolis
GSK Investigational Site, Saint Cloud
GSK Investigational Site, Flossmoor
GSK Investigational Site, Chicago
GSK Investigational Site, Chicago
GSK Investigational Site, Kharkiv
GSK Investigational Site, Urbana
GSK Investigational Site, St Louis
GSK Investigational Site, St Louis
GSK Investigational Site, Kansas City
GSK Investigational Site, Odesa
GSK Investigational Site, Zaporizhzhya
GSK Investigational Site, New Orleans
GSK Investigational Site, Fayetteville
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Dallas
GSK Investigational Site, Temple
GSK Investigational Site, Houston
GSK Investigational Site, San Antonio
GSK Investigational Site, San Antonio
GSK Investigational Site, Lviv
GSK Investigational Site, Las Vegas
GSK Investigational Site, Donetsk
GSK Investigational Site, Boise
GSK Investigational Site, Midvale
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Mesa
GSK Investigational Site, Litchfield Park
GSK Investigational Site, Tucson
GSK Investigational Site, Tucson
GSK Investigational Site, Henderson
GSK Investigational Site, Las Vegas
GSK Investigational Site, Los Angeles
GSK Investigational Site, Santa Monica
GSK Investigational Site, Luhansk
GSK Investigational Site, Pasadena
GSK Investigational Site, Santa Ana
GSK Investigational Site, Renton
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Samara
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Providencia / Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, Danbury
GSK Investigational Site, Fairfield
GSK Investigational Site, Springfield
GSK Investigational Site, Edison
GSK Investigational Site, Vorhees
GSK Investigational Site, Columbus
GSK Investigational Site, Capital Fefderal
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Santiago
GSK Investigational Site, San José
GSK Investigational Site, Kyiv
GSK Investigational Site, Poltava
GSK Investigational Site, San Juan
GSK Investigational Site, San Juan
GSK Investigational Site, Busan
GSK Investigational Site, Daegu
GSK Investigational Site, Daejeon
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Kyiv
Lead Sponsor
GlaxoSmithKline
INDUSTRY